Brennan, Paul N.

Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004

O'Toole, O., Traynor, B. J., Brennan, P., Sheehan, C., Frost, E., Corr, B., & Hardiman, O. (2008) · Journal of Neurology, Neurosurgery & Psychiatry

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research

Cited by 197

Cell therapy for advanced liver diseases: repair or rebuild

Dwyer, B. J., Macmillan, M. T., Brennan, P. N., & Forbes, S. J. (2021) · Journal of Hepatology

Liver physiology and pathologyTissue Engineering and Regenerative Medicine

Cited by 141

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach

Brennan, P. N., Elsharkawy, A. M., Kendall, T. J., Loomba, R., Mann, D. A., & Fallowfield, J. A. (2023) · Nature Reviews Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 68

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial

Brennan, P. N., MacMillan, M., Manship, T., Moroni, F., Glover, A., Troland, D., MacPherson, I., Graham, C., Aird, R., Semple, S. I. K., et al. (2025) · Nature Medicine

Liver Disease and TransplantationLiver physiology and pathology

Cited by 66

Opportunities and challenges following approval of resmetirom for MASH liver disease

Lazarus, J. V., Ivancovsky Wajcman, D., Mark, H. E., Younossi, Z. M., Kopka, C. J., Cohen, N., Bansal, M. B., Betel, M., & Brennan, P. N. (2024) · Nature Medicine

Liver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection

Cited by 60

A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease

Ivancovsky Wajcman, D., Byrne, C. J., Dillon, J. F., Brennan, P. N., Villota-Rivas, M., Younossi, Z. M., Allen, A. M., Crespo, J., Gerber, L. H., & Lazarus, J. V. (2026) · Hepatology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 33

Advances and Emerging Therapies in the Treatment of Non-alcoholic Steatohepatitis

Brennan, P. N., The University of Edinburgh, C. F. R. M., NHS Tayside, N. H. A. M. S., The University of Dundee, D. O. M. A. C. M., Dillon, J. F., NHS Tayside, N. H. A. M. S., The University of Dundee, D. O. M. A. C. M., McCrimmon, R., NHS Tayside, N. H. A. M. S., & The University of Dundee, D. O. M. A. C. M. (2022) · European Endocrinology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 3

LBP-007 Beneficial effects of autologous macrophage therapy on clinical outcomes in patients with compensated cirrhosis: extended follow-up data from a randomized controlled phase 2 trial

Brennan, P., Macpherson, I., Troland, D., Kilpatrick, A. M., Manship, T., McGowan, N., Campbell, J., Fraser, A., Pass, C., Moroni, F., et al. (2024) · Journal of Hepatology

Liver Disease and TransplantationLiver physiology and pathology

Cited by 3